Pillars of Progress
Overview
API
R&D
CRAMS
Company
Overview
Board of directors
Leadership
Innovation
Products
Responsibility
Investor Relations
Financial Information
Disclosure under Regulation 46 of SEBI (LODR) Regulations
Rights Issue
Others
News and Announcements
Careers
Overview
People
Contact
Employee Login
Solara Active Pharma Sciences
Investor Relations
Investor Update
Board Meeting
General Meeting
Press / Media Release
General Announcements
Shareholding Pattern
Investor Update
Q2 F.Y. 2026
Q1 F.Y. 2026
Q4 F.Y 2025
Q3 F.Y 2025
Q2 F.Y 2025
Q1 F.Y 2025
Q4 F.Y 2024
Q3 F.Y 2024
Q2 F.Y 2024
Q1 F.Y 2024
Q4 F.Y 2023
Q3 F.Y 2023
Q2 F.Y 2023
Q1 F.Y 2023
Q4 F.Y 2022
Q3 F.Y 2022
Q2 F.Y 2022
Q1 F.Y 2022
Q4 F.Y 2021
Q3 F.Y 2021
Q2 F.Y 2021
Q1 F.Y 2021
Q4 F.Y 2020
Q3 F.Y 2020
Q2 F.Y 2020
Q1 F.Y 2020
Q4 F.Y 2019
Q3 F.Y 2019
Q2 F.Y 2019
Q1 F.Y 2019
Q4 F.Y 2018
Investors presentation and Press release
Download
Investors Con-call-Audio Recording
Download
